Abstract
Kyowa Hakko Kirin, AstraZeneca and subsidiaries are developing benralizumab (Fasenra (TM))-a humanised anti-interleukin-5 receptor alpha chain (IL-5R ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
